|
|
|
Examining different parts of the immune system, OU Health Sciences Center and Washington University in St. Louis researchers are creating a new vaccine using a protein instead of creating antibodies.
The importance of linking services of Sexual and Reproductive Health and Human Immunodeficiency Virus (HIV) is now widely recognized. Linkages between core HIV services (prevention, treatment, care, and support), and core SRH services (Family Planning, Maternal and Newborn Care, the prevention and management of Sexually Transmitted Infections, Reproductive Tract Infections, promotion of sexual health…) in national programmes are thought to generate important public health benefits. Those benefits include improved access to and uptake of key HIV and SRH services; better access of People Living with HIV (PLHIV) to SRH services customized to their needs; reduction in HIV-related stigma and discrimination; improved coverage of key populations; greater support for dual protection; improved quality of care; and decreased duplication of efforts and competition for scarce resources (IPPF, UNFPA, WHO, UNAIDS, GNP+, ICW, Young Positives, 2009).
JOHANNESBURG — A leader in the search for a vaccine against HIV, which causes AIDS, said Friday that recent advances have given scientists new reason for hope.
Community members gathered at St. Mark's Episcopal Church, today, to raise awareness for HIV and AIDS.
The AIDS virus damages the immune system differently than scientists have thought until now, a study on a bacterial infection indicates.
(MENAFN - Jordan Times) A total of 28 people have tested positive for HIV/AIDS in Jordan since the beginning of the year, a health official said on Sunday.
HIV infects women by weakening a cell barrier in the reproductive tract that normally keeps viruses out, Canadian researchers have discovered.
UCSF researchers have found a novel association between human papillomavirus (HPV) infection and increased HIV acquisition in women. The study team also identified specific types of HPV associated with HIV infection, suggesting a biological basis for HIV transmission to women.
The good news is we’re living longer with HIV. The bad news is we’re aging faster than those not infected HIV. The body’s hyperactive response to the virus, even among those being successfully treated with antiretrovirals, is being eyed as the culprit. Fortunately, researchers already have potential anti-aging and anti-inflammatory treatments in sight.
San Francisco public health doctors are urging patients to begin taking HIV medications soon after their diagnosis rather than waiting until their immune systems become compromised, The New York Times reports. The city’s Department of Public Health will announce the new testing guidelines this week.
The risk of transmitting HIV is significantly reduced in people on successful antiretroviral therapy for more than six months, according to Danish investigators and reported on by aidsmap. The Danish study is published in the online edition of the journal HIV Medicine.
The introduction of rapid tests for HIV and hepatitis is an extremely important development not only from the point of view of streamlining the medical tests and saving time, but from the psychological trauma of the stress of waiting
for the result.
BANGKOK – UNAIDS, backed by hundreds of parliamentarians, called Sunday for the lifting of travel restrictions on HIV-positive people which are still by imposed by 52 countries.
London, Mar 29 : Providing antibiotics to some newly diagnosed HIV patients could save tens of thousands of patients, but researchers are missing this opportunity, say researchers.
SMYRNA, Ga., March 30 /March 30, 2010l/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops, and tests innovative HIV/AIDS vaccines, is now allowed by the FDA (US Food and Drug Administration) to begin a phase 1 clinical trial for GeoVax's therapeutic vaccine, which is intended as a treatment for individuals infected with HIV (Human Immunodeficiency Virus). The company will begin a non-blinded study in HIV infected individuals who started drug treatment during their first year of infection.
Scientists from the California Institute of Technology (Caltech) have uncovered the structure of key protein in common HIV subgroup.
During a meeting of lawmakers from 150 countries in Bangkok, UNAIDS Executive Director Michel Sidibe on Sunday warned that the global economic crisis could reverse recent gains in the fight against HIV/AIDS, Reuters reports. An estimated 33.4 million people in the world are living with HIV/AIDS, the news service notes.
NAIROBI, 15 December 2009 (PLUSNEWS) - The executive board of UNITAID, the international health financing agency, has approved the establishment of a patent pool for HIV/AIDS medication, a decision AIDS activists say will go a long way in helping poor nations achieve universal access to treatment.
NAIROBI, 7 December 2009 (PLUSNEWS) - If universal access to HIV prevention, treatment and care is to be achieved, experts recommend an inclusive approach to healthcare, rather than narrow HIV programmes.
JOHANNESBURG, 8 March 2010 (PLUSNEWS) - Achieving targets to eliminate mother-to-child transmission of HIV and halve tuberculosis rates hang in the balance as donor commitments to the Global Fund to Fight AIDS, Tuberculosis and Malaria Fund come up for review.
Hopes for HIV eradication have been stymied by the current crop of antiretroviral drugs’ inability to get at the reservoir of inactive HIV-infected CD4 cells that hide in the body. Now, Robert Siliciano, MD, PhD, from Johns Hopkins University says not only that it’s possible to get at these cells, but that his lab is already on track to identifying drugs that can wake up these cells. The discovery represents a significant step on the path to ultimately curing HIV.
If an HIV vaccine became available tomorrow, would the world line up for it? It depends on the level of protection it affords, says a research team from the University of California at Los Angeles.
A new vaccine called mycobacterium vaccae (MV) might prevent tuberculosis (TB) in HIV-positive people, according to a new study published in the journal AIDS and reported on by HealthDay News. TB is the most common cause of death among HIV-positive people indeveloping countries.
Researchers found a new antiviral drug that appears to effectively target not only HIV, but also Ebola, influenza and Rift Valley fever, according to a study published online January 28 in the Proceedings of the National Academy of Sciences.
People with HIV can achieve just as much benefit from treatment in “real world” clinics as they do in clinical trials, according to a University of Alabama at Birmingham (UAB) study published February 15 in Clinical Infectious Diseases and reported by aidsmap.
JUBA, 4 February 2010 (PLUSNEWS) - Networks of people living with HIV insouthern Sudan are trying to overcome deficiencies in the limping healthsystem and broken infrastructure by spreading information about the pandemicand reducing stigma and denial.
Writing as the co-founder of the Bill & Melinda Gates Foundation, Bill Gates discussed HIV/AIDS in his annual letter. The Microsoft billionaire-turned-philanthropist stressed the importance of scaling up prevention efforts such as male circumcision, ensuring access to care in developing countries and supporting vaccine research.
A research team from the University of Missouri at Columbia is developing a novel nucleoside reverse transcriptase inhibitor (NRTI) that remains active against HIV for days after a single dose, according to a report published online by ScienceDaily. Stefan Sarafianos, PhD, who heads to the MU team, said the compound is more potent and longer-lasting than current NRTIs and may find use not only as a component of antiretroviral (ARV) therapy but also as a preventive microbicide.
If an HIV vaccine became available tomorrow, would the world line up for it? It depends on the level of protection it affords, says a research team from the University of California at Los Angeles.
NAIROBI, 1 February 2010 (PLUSNEWS) - Scientists have finally discovered the structure of a key enzyme found in HIV and similar viruses, abreak through that has crucial implications for HIV treatment.
CAIRO, 30 December 2009 (IRIN) - A new report says Egypt is moving towards a"concentrated HIV epidemic", as an increasing number of HIV patients arebeing recorded.
Do you know anyone who is HIV positive? The NGO "Think Positive" asked around
JOHANNESBURG, 30 November 2009 (PLUSNEWS) - Some headway has been made in mitigating the impact of HIV/AIDS on children and young people, but too many are still needlessly infected, and receive little or no treatment, care and support.
NAIROBI, 30 November 2009 (PLUSNEWS) - The World Health Organization (WHO) issued a new set of guidelines for the treatment of HIV and prevention of mother-to-child transmission (PMTCT) on 30 November.
"EIGHT-YEAR TREND SHOWS NEW HIV INFECTIONS DOWN BY 17%—MOST PROGRESS SEEN IN SUB-SAHARAN AFRICA "
JOHANNESBURG, 25 November 2009 (PLUSNEWS) - That women and girls are particularly vulnerable to HIV and AIDS is well established, but a new report reveals how little we know about what countries are doing, or not doing, to address their vulnerability.
JOHANNESBURG, 24 November 2009 (PLUSNEWS) - The rate of new HIV infections worldwide has declined by 17 percent in the past eight years and prevention efforts can take some of the credit, according to the annual UNAIDS update on the epidemic released on 24 November.
Addis Ababa – The Global Fund to Fight AIDS, Tuberculosis and Malaria’s Board of Directors has made an overall approval of grants with a two-year commitment of US$2.4 billion.
NAIROBI, 12 November 2009 (PLUSNEWS) - The United Nations Convention on the Rights of Persons with Disabilities (CRPD) should be used as a tool to improve access to HIV services for disabled people, who are often marginalized in national HIV policies, says a new report.
NAIROBI, 11 November 2009 (PLUSNEWS) - Programmes supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria reported 2.3 million people on life-prolonging antiretroviral (ARV) drugs in June 2009. Funding to beneficiary countries is based on performance, and failure to meet targets can lead to delays, suspension, discontinuation or termination of grants.
JOHANNESBURG, 5 November 2009 (PLUSNEWS) - Wavering international support for HIV/AIDS efforts is resulting in funding shortfalls that could wipe out a decade of progress in rolling out AIDS treatment, the international medical and humanitarian organization, Médecins Sans Frontières (MSF), has warned.
The Saudi Charity Association for AIDS Patients Our Commitment to fight HIV…
By Michael Weinstein & Dr. Homayoon Khanlou, M.D.
JOHANNESBURG, 22 October 2009 (PLUSNEWS) - The recent news that for the first time an HIV vaccine had shown some protective effect generated widespread excitement, until it emerged that the results were based on the most promising of three different analyses of the trial findings.
JOHANNESBURG, 24 September 2009 (PLUSNEWS) - A six-year clinical trial in Thailand has yielded the first ever evidence that an AIDS vaccine can provide some protection against HIV infection.
DAKAR, 15 October 2009 (IRIN) - For decades diarrhoea has been a stealth killer, claiming more under-five children than AIDS, malaria and measles combined, yet it remains a neglected disease, according to World Health Organization diarrhoea specialist Olivier Fontaine. "We made huge progress in the 1980s, but donor investment decreased in the 1990s as attention was diverted to AIDS, tuberculosis and malaria."
An Interview With Jeffrey Laurence, M.D.By Bonnie Goldman
AMSTERDAM / BALI / GENEVA / LONDON / NEW YORK, 11 August 2009 – People living with HIV and their advocates today launched a groundbreaking guidance package,
NAIROBI, 7 August 2009 (PLUSNEWS) - The Clinton Foundation has announced agreements with two drug companies to bring the cost of second-line antiretrovirals (ARVs) to under US$500 per person annually and reduce the cost of a key tuberculosis (TB) drug to $1 per dose.
Scientists say they have decoded the entire genetic structure of HIV-1 - the main cause of Aids in humans.
JOHANNESBURG, 14 July 2009 (PLUSNEWS) - Figuring out safe sex is hard enough, but if you are a woman who has sex with other women, no one is saying much about the methods available for preventing sexually transmitted infections. South African film director Beverley Palesa Ditsie spoke to IRIN/PlusNews about why she started using protection with her partners, and why more research on the risk of female-to-female HIV transmission is necessary.
JOHANNESBURG, 16 July 2009 (PLUSNEWS) - Pharmaceutical company GlaxoSmithKline (GSK) has announced plans to invest up to US$97 million over 10 years in improving antiretroviral (ARV) treatment for children and adults in sub-Saharan Africa.
Focus to shift from US priorities to those of countries receiving aid.
JOHANNESBURG, 17 July 2009 (PLUSNEWS) - New research suggests that circumcising HIV-positive men does not reduce the risk of their female
JOHANNESBURG, 28 July 2009 (PLUSNEWS) - The goal of achieving universal
CAPE TOWN, 21 July 2009 (PLUSNEWS) - While the worldwide AIDS community bemoans the global economic crisis and its impact on funding streams for the HIV/AIDS response, several speakers at the 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention, taking place in Cape Town, South Africa, this week, called on mplementers to start doing more with less.
CAPE TOWN, 21 July 2009 (PLUSNEWS) - The idea of using antiretroviral drugs (ARVs) not only to treat HIV infection but also to prevent new infections,and eventually to eradicate the virus almost entirely, is being hotly debated at the 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Cape Town, South Africa, this week.
CAPE TOWN, 22 July 2009 (PLUSNEWS) - Alcohol and drug addiction are major drivers of the HIV/AIDS epidemic in many parts of the world, but for political and ideological reasons, scientists and clinicians have tended to shy away from this area of HIV research, while governments and donors have been reluctant to fund programmes targeting addicts.
CAPE TOWN, 20 July 2009 (PLUSNEWS) - The 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention opened on Sunday in Cape Town, South Africa, amidst reports that funding gaps and poor management are threatening supplies of life-prolonging antiretroviral (ARV) drugs in at least six African countries.
Studies have shown an increased risk for heart- and lung-related hospitalizations in people infected with HIV during influenza seasons as opposed to other times of the year, and a higher risk of influenza-related death in HIV-infected people. Other studies have indicated that influenza symptoms might be prolonged and the risk of influenza-related complications higher for certain HIV-infected people. Therefore, HIV-infected persons should be considered as a high risk and a priority population for preventive and therapeutic strategies against influenza including emerging influenza A(H1N1) virus infection.
Kampala, Nairobi and Delhi – On the eve of the G8 Summit in Italy, the International Treatment Preparedness Coalition (ITPC) calls on leaders of the world’s richest countries to announce significant additional funds to ensure that AIDS treatment and prevention programs for millions of men, women and children do not become a casualty of the economic down-turn.
Myra, 22, a mother of two, says she didn't know about the disease of her husband till his death. "I came to know when one of his friends came to our house to condole my husband's death," she said of her husband's friend who had been his co-worker abroad.
LONDON -- In the last two decades, the world has spent more than $196 billion trying to save people from death and disease in poor countries.
JOHANNESBURG, 10 June 2009 (PLUSNEWS) - Findings from a clinical trial in Haiti bring the first conclusive evidence that HIV-positive people in developing countries have asignificantly better chance of survival if they start antiretroviral (ARV) treatment earlier.
In a major breakthrough for AIDS cure, Canadian scientists have finally found where the HIV virus hides in the human body to become impervious to medical treatment.
DUBAI, 25 June 2009 (IRIN) - The number of cases of the A(H1N1) virus, otherwise known as swine flu, is growing in the Middle East, with many new suspected and confirmed cases in the past few days, but so far no one has died of the disease.
World Health Organization Maximizing Positive Synergies Collaborative Group
21 May 2009 – The head of the United Nations agency charged with coordinating the fight against HIV/AIDS has called for a virtual elimination of mother-to-child AIDS transmission worldwide by 2015.
11 June 2009 – The A(H1N1) influenza outbreak has officially reached global pandemic levels, the public health arm of the United Nations announced today, as it raised its warning system to Phase 6.
Forum
FAQ